Company / AR per Share
CRISPR Therapeutics AG AR per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.29
FY2024
5-year range
$0.00 / $2.50
FY2020-FY2024
Trend
-88.3%
vs FY2023
Sector context
#79 of 112
Health Care
What the data says
At $0.29, CRISPR Therapeutics AG's ar per share ranks #79 of 112 in the Health Care sector. AR per Share has fluctuated over the past 9 years, ranging from $0.00 in FY2022 to $2.50 in FY2023.
Based on SEC 10-K filings.
0.29 in FY2024 with a 5-year CAGR of +173.4%.
Improved from $0.00 to $0.29 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +319.1%
- 5-Year CAGR
- +173.4%
- 10-Year CAGR
- -
Sector benchmark
#79 of 112 in Health CareTop 71% of 112This company $0.29 Sector average $29.00
▼
-99.0% below sector average
Key checks
Key Insights
- In FY2024, ar per share decreased 88.3% year-over-year.
- Ranks #79 out of 112 companies in the Health Care sector.
- Peak ar per share was recorded in FY2023.
- Lowest ar per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.29 | -88.3% |
| FY2023 | $2.50 | - |
| FY2022 | $0.00 | -100.0% |
| FY2021 | $0.00 | +103.3% |
| FY2020 | $0.00 | +2.0% |
| FY2019 | $0.00 | -11.9% |
| FY2018 | $0.00 | -96.7% |
| FY2017 | $0.07 | -88.4% |
| FY2016 | $0.57 | +748.6% |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026